Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1964-1969

  Urasaki, Yoshimasa ^a   Laco, Gary S ^a   Pourquier, Phillipe ^a   Takebayashi, Yuji ^b   Kohlhagen, Glenda ^a   Gioffre, Christopher ^a   Zhang, Hongliang ^a   Chatterjee, Devasis ^c   Pantazis, Panayotis ^c   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE;

ARTICLE; CANCER CELL CULTURE; CATALYSIS; CROSS RESISTANCE; CRYSTAL STRUCTURE; DNA CLEAVAGE; DNA SUPERCOILING; ENZYME ACTIVE SITE; GENE TARGETING; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CAMPTOTHECIN; CATALYSIS; DNA TOPOISOMERASES, TYPE I; DNA, VIRAL; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIMIAN VIRUS 40; TUMOR CELLS, CULTURED;

EID: 0035266161     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cure of leukemia
2. The lymphomas
3. Management of testicular seminoma
4. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: The ALL90 study of the Japan Adult Leukemia Study Group
5. The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma
6. New developments in the treatment of acute myeloid leukemia: Focus on topotecan
7. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I
8. Replication-mediated, DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA: DNA-PK complexes
9. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff
10. Topoisomerase, I. Inhibitors: Selectivity and cellular resistance
11. Eukaryotic DNA topoisomerases I
12. Crystal structure of human topoisomerase I in covalent and noncovalent complexes with DNA
13. A model for the mechanism of human topoisomerase I
14. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin
15. Isolation of a human prostate carcinoma cell line (DU 145)
16. Induction of apoptosis in malignant and camptothecin-resistant human cells
17. Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector
18. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. Position-specific trapping of topoisomerase I-DNA cleavage complexes by the intercalated benzo[a]pyrene diol epoxide adducts at the 6-amino group of adenine
21. Topoisomerase I and II activity assays
22. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove
23. Induction of topoisomerase I cleavage complexes by 1-β-D-arabino-furanosylcytosine (ara-C) in vitro and in ara-C-treated cells
24. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps: Importance of DNA end phosphorylation and camptothecin effects
25. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo [2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506): Induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity
26. Characterization of a mammalian mutant with a camptothecin resistant DNA topoisomerase I
27. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content
28. Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines
29. Nonproductive rearrangement of DNA topoisomerase I and II genes: Correlation with resistance to topoisomerase inhibitors
30. Characterization of camptothecin-resistant Chinese hamster lung cells
31. Camptothecin hyper-resistant P388 cells: Drug-dependent reduction in topoisomerase I content
32. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin
33. Structural insights into the function of type IB topoisomerases
34. A high affinity topoisomerase I binding sequence is clustered at DNase I hypersensitive sites in Tetrahymena R-chromatin
35. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons
36. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages
37. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site
38. Identification of a mutant human topoisomerase I with intact catalytic and resistance to 9-nitro -camptothecin
39. Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis
40. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine
41. Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture
42. Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance
43. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites
44. Mechanism of resistance in a human cell line exposed to sequential topoisomerase poisoning
45. Identification of mutations of DNA topoisomerase I response for camptothecin resistance
46. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants
47. Silencing and selective methylation of the normal topoisomerase I gene in camptothecin-resistant CEM/C2 human leukemia cells
48. Detection of topoisomerase I gene point mutation in CPT-II resistant lung cancer cell line